An estimated 107 million US adults used wearable health devices in 2024, marking a 58% increase since 2019, according to data covered by Medscape. While 74 million Americans reported routine use—including 37 million managing obesity—clinicians and researchers warn that insufficient clinical validation and data-driven anxiety remain significant hurdles for medical integration.
How Many Americans Used Wearable Health Devices in 2024?
Consumer adoption of wearable technology reached new highs in 2024, with approximately 107 million US adults strapping on fitness trackers, smartwatches, or biosensors. This figure represents a 58% surge compared to 2019 adoption rates, Medscape reported. Out of that total user base, 74 million individuals reported routine use of their devices.
Weight management serves as a primary driver for much of this growth. An estimated 37 million adults with obesity utilize these technologies specifically to track weight-loss efforts and physical activity. Beyond simple step-counting, interest is expanding rapidly into chronic condition management, particularly gastrointestinal (GI) disorders.
Can Wearable Patches Predict Inflammatory Bowel Disease Flares?
Researchers are investigating whether consumer and medical-grade wearables can forecast health crises before symptoms physically manifest. In gastroenterology, wearable applications include monitoring autonomic and muscular correlates of visceral pain in motility disorders such as irritable bowel syndrome and noting limitations of sweat-based devices, according to Saurabh Chawla.
Specialized patches measuring heart rate variability (HRV) capture physiologic stress that often precedes inflammatory bowel disease (IBD) flares. Studies cited by Chawla and colleagues reveal that fluctuations in HRV successfully predicted ulcerative colitis and IBD flares up to 7 weeks prior to clinical detection. Furthermore, a small feasibility study showed that tracking wrist-worn data prompted ulcerative colitis patients to proactively contact their physicians.
Additional noninvasive monitoring methods include biosensor patches designed to detect inflammatory markers in sweat. The IBD AWARE device tapes to the torso to monitor tumor necrosis factor-alpha (TNF-alpha) and other inflammatory cytokines. In preliminary studies, sweat TNF-alpha levels were significantly elevated in IBD patients compared to healthy control groups. However, Chawla noted that sweat-based monitoring faces limitations, including sample impurities and variability caused by temperature and humidity fluctuations.
Why Do Gastroenterology Patients Want Remote Monitoring Tools?
Patient enthusiasm for digital health monitoring runs high, particularly among those dealing with chronic GI conditions. A study by Godecharle and colleagues involving 1,080 adults with IBD found that nearly 28.7% actively used wearables, with over half of the study cohort aged 50 or older. More than 90% of participants agreed that wearables could effectively support remote monitoring for flare detection.
Shorter disease duration, frequent flares, younger age, and existing device ownership emerged as the primary predictors of willingness to adopt these tools. Despite this enthusiasm, Chawla cautioned that it remains “still too soon to incorporate them into routine clinical practice due to insufficient validation,” pointing to the need for large-scale clinical trials that include patients with severe disease states.
Do Continuous Glucose Monitors Change Eating Behaviors and Weight?
Real-time physiological feedback can alter daily choices, though the extent of its impact on actual weight loss remains debated. Michael Snyder, professor in the Department of Genetics and director of the Center of Genomics and Personalized Medicine at Stanford University School of Medicine, advocates for continuous glucose monitor (CGM) use among the general public.
“If you drink a McDonald’s shake, you’ll watch your glucose spike in real time, and you’ll probably never drink one again, or if you do, at least you’ll think twice about it,” Snyder told Medscape. He pointed to meta-analysis evidence indicating that CGM usage helps users improve time-in-range and support weight loss by visualizing how diet affects blood sugar.
Collin Popp, PhD, MS, RD, assistant professor in the Department of Population Health at NYU Langone Health, noted that even missed activity targets provide useful insights. In a study co-authored by Popp, 39 adults with overweight, obesity, and prediabetes or moderately controlled type 2 diabetes used smartphone food logs, wrist-motion sensors, and CGMs for 10 days. The technology captured overlapping eating occasions that helped refine dietary interventions.
However, adding consumer wearables to structured weight-loss programs does not always guarantee superior outcomes. The IDEA trial evaluated 417 participants with overweight or obesity placed on low-calorie diets and physical activity regimens. At 24 months, the group assigned to a wearable-enhanced intervention lost less weight than the standard behavioral intervention group, shedding 3.5 kg compared to 5.9 kg.
Why Does Constant Health Data Trigger Anxiety and Distress?
Continuous access to personal metrics can backfire by inducing psychological distress and misinterpretation of normal physiological variations. Popp described a patient who stopped eating blueberries after observing a normal postprandial glucose rise on an over-the-counter CGM, mistaking a healthy food response for a medical warning.
A study by Richardson and colleagues evaluating 56 adults found that over two thirds of participants reported fear of type 2 diabetes when observing high glucose readings. Additionally, Chawla observed that sleep tracking frequently triggers self-reinforcing loops of worry when patients feel well-rested yet receive poor sleep scores from their devices.
Did you know?
Data gathered by consumer health apps and personal devices do not automatically receive protection under the Health Insurance Portability and Accountability Act (HIPAA) unless provided directly by a covered medical entity.
What Privacy and Practical Barriers Limit Clinical Integration?
Integrating consumer wearables into everyday medical workflows introduces major hurdles regarding data privacy, digital literacy, and financial access. Chawla emphasized that device costs and digital literacy gaps prevent uniform access across socioeconomic lines.
Personal health apps generally fall outside federal HIPAA guidelines unless directly associated with a healthcare provider, leaving patients vulnerable regarding who accesses or shares their data. Finally, the sheer volume of incoming biometric data creates logistical challenges for medical practices that lack dedicated workflows to review continuous patient feeds.
Common Questions About Wearable Health Technologies
What percentage of US adults used wearables in 2024?
An estimated 107 million US adults used wearable devices in 2024, representing a 58% increase since 2019.
How do wearable patches detect IBD flares?
Wearable patches measure physiological metrics like heart rate variability (HRV) and sweat cytokine levels—such as TNF-alpha—which fluctuate ahead of disease flares.
Do CGMs automatically qualify for HIPAA privacy protections?
No. US Department of Health and Human Services guidance notes that personal health app data falls outside HIPAA unless the app is provided by a covered healthcare entity or its business associate.
Did wearable devices improve long-term weight loss in clinical trials?
In the IDEA trial, participants assigned to a wearable-enhanced weight loss intervention lost less weight at 24 months (3.5 kg) compared to a standard behavioral intervention group (5.9 kg).
Related reading